A Double-Blind, Randomized, Placebo-Controlled Phase 3 Study of Orally administered PLX3397 in Subjects with Pigmented Villonodular Synovitis or Giant Cell Tumor of the Tendon Sheath
Clinical Trial Grant
Administered By
Duke Cancer Institute
Awarded By
Daiichi Pharmaceutical Corporation
Start Date
August 1, 2015
End Date
July 31, 2021
Administered By
Duke Cancer Institute
Awarded By
Daiichi Pharmaceutical Corporation
Start Date
August 1, 2015
End Date
July 31, 2021